How much does a box of Duvelisib capsules cost?

Duvelisib (Duvelisib) is a new type of anti-cancer drug that is a leukocyte signaling pathway inhibitor. Its main function is to inhibit signaling pathways such as phosphatidylinositol 3kinase (PI3K) and phospholipase D (PLD), which play an important role in the development of various leukemias and lymphomas.

The original drug of Duvelisel Capsules has been launched in China, but it is not covered by medical insurance. Patients can buy it domestically at a price of more than 20,000 yuan. For specific prices, please consult the local hospital pharmacy.

Duveliced has been approved for the treatment of different types of lymphomas and leukemias, including T cell lymphoma, chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). This makes it a broad-spectrum treatment option. Duvelicet blocks the growth, differentiation and survival of malignant cells by inhibiting signaling pathways such as PI3K and PLD, thereby inhibiting the progression of the disease.

Unlike traditional leukocyte signaling pathway inhibitors, duvelised affects both the PI3K and PLD signaling pathways. This unique mechanism is expected to provide better therapeutic effects for some patients. Duveliced u200bu200bis primarily used to treat patients who are not candidates for the drug or have experienced relapse. It offers these patients a new treatment option with the potential to improve disease control and survival.

Although the use of duvelisel may cause some adverse reactions, such as infection, nausea, diarrhea, etc., under the supervision of a doctor, it can provide hope for patients with leukemia and lymphoma. The development of duvliside represents an important breakthrough in cancer treatment, providing new treatment strategies, especially for patients who need more options.